Jun-Jiang Chen

429 total citations
20 papers, 367 citations indexed

About

Jun-Jiang Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jun-Jiang Chen has authored 20 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Jun-Jiang Chen's work include Drug Transport and Resistance Mechanisms (6 papers), Pregnancy and preeclampsia studies (2 papers) and Air Quality and Health Impacts (2 papers). Jun-Jiang Chen is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pregnancy and preeclampsia studies (2 papers) and Air Quality and Health Impacts (2 papers). Jun-Jiang Chen collaborates with scholars based in China, United States and Hong Kong. Jun-Jiang Chen's co-authors include Zhe‐Sheng Chen, Zhijie Xiao, Dong‐Hua Yang, Kamlesh Sodani, Ruochun Huang, Atish Patel, Weimin Yang, Tanaji T. Talele, Qi Zhou and Ruo‐Pan Huang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical Pharmacology.

In The Last Decade

Jun-Jiang Chen

19 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun-Jiang Chen China 10 180 143 75 54 38 20 367
Sayed Mostafa Hosseini Iran 10 106 0.6× 142 1.0× 83 1.1× 104 1.9× 24 0.6× 29 336
J-Y. Lee South Korea 12 98 0.5× 247 1.7× 35 0.5× 102 1.9× 24 0.6× 27 447
Anca Zgură Romania 10 149 0.8× 69 0.5× 38 0.5× 45 0.8× 60 1.6× 51 398
Xingdong Cai China 10 74 0.4× 167 1.2× 55 0.7× 79 1.5× 20 0.5× 23 330
Kateřina Pospěchová Czechia 10 90 0.5× 104 0.7× 53 0.7× 35 0.6× 63 1.7× 14 349
Natasha P. Clayton United States 13 69 0.4× 158 1.1× 94 1.3× 82 1.5× 32 0.8× 29 510
Jingzhe Sui China 13 76 0.4× 199 1.4× 65 0.9× 80 1.5× 82 2.2× 21 380
Nanya Wang China 13 148 0.8× 150 1.0× 120 1.6× 71 1.3× 37 1.0× 29 450
Juan Pu China 15 75 0.4× 241 1.7× 62 0.8× 161 3.0× 58 1.5× 35 481
Bo Qiao China 11 34 0.2× 168 1.2× 55 0.7× 36 0.7× 16 0.4× 21 947

Countries citing papers authored by Jun-Jiang Chen

Since Specialization
Citations

This map shows the geographic impact of Jun-Jiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Jiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Jiang Chen more than expected).

Fields of papers citing papers by Jun-Jiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Jiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Jiang Chen. The network helps show where Jun-Jiang Chen may publish in the future.

Co-authorship network of co-authors of Jun-Jiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-Jiang Chen. A scholar is included among the top collaborators of Jun-Jiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-Jiang Chen. Jun-Jiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yitong, et al.. (2025). TRIM3 suppressed the tumorigenicity of melanoma cells by ubiquitinating YAP1. Scientific Reports. 15(1). 27264–27264.
2.
Shi, Yuan, et al.. (2022). Synthesis, crystal structure and DFT study of 4-amino-6-[[(1,3-dimethoxyphenyl)methyl]amino]-5-pyrimidine carbaldehyde. Molecular Crystals and Liquid Crystals. 745(1). 93–101. 1 indexed citations
3.
Zhang, Ruyi, Chang-Meng Wu, Xiumei Hu, et al.. (2021). LncRNA AC105942.1 Downregulates hnRNPA2/B1 to Attenuate Vascular Smooth Muscle Cells Proliferation. DNA and Cell Biology. 40(5). 652–661. 13 indexed citations
4.
Zhang, Xuelian, Xinyi Zhao, Yongquan Wu, et al.. (2021). Angiotensin(1–7) activates MAS-1 and upregulates CFTR to promote insulin secretion in pancreatic β-cells: the association with type 2 diabetes. Endocrine Connections. 11(1). 3 indexed citations
5.
Li, Xiaoyan, Jun-Jiang Chen, Yange Wang, et al.. (2020). Development of a droplet digital PCR method for detection of Streptococcus agalactiae. BMC Microbiology. 20(1). 179–179. 15 indexed citations
6.
Chen, Jun-Jiang, et al.. (2020). Design and Implement Robust Wireless Network Based on TCP Protocol. 7. 252–261. 1 indexed citations
7.
8.
Chen, Jun-Jiang, Zhijie Xiao, Xiaojing Meng, et al.. (2019). MRP4 sustains Wnt/β-catenin signaling for pregnancy, endometriosis and endometrial cancer. Theranostics. 9(17). 5049–5064. 37 indexed citations
10.
Sun, Xiao, Jinghui Guo, Dan Zhang, et al.. (2018). Activation of the epithelial sodium channel ( EN aC) leads to cytokine profile shift to pro‐inflammatory in labor. EMBO Molecular Medicine. 10(10). 9 indexed citations
11.
Chen, Jun-Jiang, et al.. (2018). PM2.5 exposure aggravates left heart failure induced pulmonary hypertension. Acta cardiologica. Supplementum. 74(3). 238–244. 23 indexed citations
12.
Chen, Jun-Jiang, et al.. (2017). MRP4 regulates ENaC-dependent CREB/COX-2/PGE2 signaling during embryo implantation. Oncotarget. 8(45). 78520–78529. 6 indexed citations
13.
Zhang, Fengxiang, et al.. (2014). Association Between −1562C>T Polymorphism in the Promoter Region of Matrix Metalloproteinase-9 and Coronary Artery Disease: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(2). 98–105. 11 indexed citations
14.
Kathawala, Rishil J., Jun-Jiang Chen, Yunkai Zhang, et al.. (2014). Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. International Journal of Oncology. 44(5). 1634–1642. 26 indexed citations
15.
Chen, Jun-Jiang, Atish Patel, Kamlesh Sodani, et al.. (2013). BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10). PLoS ONE. 8(9). e74573–e74573. 15 indexed citations
16.
Chen, Jun-Jiang, Yue-Li Sun, Kamlesh Sodani, et al.. (2013). Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. 2(4). 306–317. 7 indexed citations
17.
Sodani, Kamlesh, Amit K. Tiwari, Satyakam Singh, et al.. (2012). GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance. Biochemical Pharmacology. 83(12). 1613–1622. 53 indexed citations
18.
Shi, Zhi, Weimin Yang, Dong‐Hua Yang, et al.. (2012). Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Research and Treatment. 135(3). 737–747. 100 indexed citations
19.
Zhang, Dongmei, Chang Shu, Jun-Jiang Chen, et al.. (2012). BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo. Molecular Pharmaceutics. 9(11). 3147–3159. 42 indexed citations
20.
Chen, Jun-Jiang. (2007). Design of CCD FTF4052M driver system with high sensitivity. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026